Drug intelligence / Profile preview

glipizide GITS

Development stage
Unknown
Lead developer
Pfizer
Modality
Small Molecules
Administration
Oral
01

Overview

Glipizide GITS (Gastrointestinal Therapeutic System) is an oral blood-glucose-lowering drug of the sulfonylurea class formulated as a once-a-day controlled release tablet. It works by stimulating the release of insulin from the pancreas, an effect dependent upon functioning beta cells in the pancreatic islets. The insulinotropic response to meals is enhanced with glipizide GITS administration in diabetic patients. The medication is contained within a non-absorbable shell specially designed to slowly release the drug so the body can absorb it gradually, maintaining effective plasma concentrations throughout the 24-hour dosing interval with less peak-to-trough fluctuation than twice-daily dosing of immediate-release glipizide.

Brand names
GLUCOTROL XLGlipizide XLMINIDIAB OD
Other names
Gastrointestinal Therapeutic System
02

Targets

SUR1 (Sulfonylurea receptor 1)

Beyond the preview

Go deeper on glipizide GITS.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on glipizide GITS.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call